A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
NeoTX Therapeutics Ltd.
Actym Therapeutics, Inc.
Sotio Biotech Inc.
NGM Biopharmaceuticals, Inc
Pfizer
NGM Biopharmaceuticals, Inc
Candel Therapeutics, Inc.
Xencor, Inc.
A&G Pharmaceutical Inc.
Calithera Biosciences, Inc
AbbVie
AbbVie
Eli Lilly and Company
Infinity Pharmaceuticals, Inc.
MacroGenics
Incyte Corporation
Incyte Corporation
Bayer
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Valerio Therapeutics
Valerio Therapeutics
University of Chicago